Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mackenzie Sennett

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of the American Academy of Dermatology|February 4, 2025
Systemic sclerosisGalen T Foulke, Mackenzie Sennett, Matthew F Helm
Biomedicines|August 26, 2023
Nab-Paclitaxel and Gemcitabine as First-Line Treatment of Metastatic Ampullary Adenocarcinoma with a Novel <i>R-Spondin2</i> RNA Fusion and <i>NTRK3</i> MutationMaryknoll P Linscott, Havell Markus, Mackenzie Sennett, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of the American Academy of Dermatology|February 4, 2025
Systemic sclerosisGalen T Foulke, Mackenzie Sennett, Matthew F Helm
Biomedicines|August 26, 2023
Nab-Paclitaxel and Gemcitabine as First-Line Treatment of Metastatic Ampullary Adenocarcinoma with a Novel <i>R-Spondin2</i> RNA Fusion and <i>NTRK3</i> MutationMaryknoll P Linscott, Havell Markus, Mackenzie Sennett, et al.
Pageof 1